Interstitial Lung Disease Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed by a specialist team with one of the following lung conditions: idiopathic pulmonary fibrosis (IPF), a type of lung scarring called idiopathic fibrotic nonspecific interstitial pneumonia (NSIP), chronic hypersensitivity pneumonitis (HP), or an unclassified interstitial lung disease (ILD) where any of the above are being considered as possible diagnoses
• People whose lung scans (a detailed type of CT scan) show signs of scarring or structural changes in the lungs
• People whose blood oxygen level, measured by a fingertip sensor while resting and breathing normal air, is 92% or above
• People whose condition has been medically stable for at least the past 6 weeks
• People who can read and write in English fluently

Who may not be able to join:

• People for whom exercise testing would not be medically safe — for example, due to a significant heart, muscle, bone, or nerve condition (confirm with trial site)
• People who have another significant lung or other health condition that a doctor determines could affect their ability to exercise or maintain adequate oxygen levels
• People whose lung function test results fall below certain thresholds — specifically, a breathing capacity (FVC) below 50% or a gas transfer measurement (DLCO) below 25% of what is expected
• People who have taken the steroid medication prednisone at a dose higher than 10 mg per day for more than 2 weeks, within the 3 months before their first study visit
• People who have a cardiac pacemaker or any metal or electronic device inside their body

Important: Always verify eligibility with the trial site directly before applying.